首页 › 特应性皮炎（湿疹） › 得克萨斯州 › Dallas
Dallas TX 特应性皮炎（湿疹）临床试验
8项针对 特应性皮炎（湿疹）的研究正在 Dallas及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
招募中观察性研究
- Reveal Research Institute - Dallas- Site Number : 8400012, Dallas
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
招募中2 期
- Novartis Investigative Site, Dallas
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
招募中2 期
- Investigational Site, Dallas
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
招募中2 期
- Enveda Investigative Site, Dallas
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
招募中3 期
- Dermatology Treatment and Research Center /ID# 265812, Dallas
- Modern Research Associates /ID# 263852, Dallas
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
招募中2 期
- Dermatology Treatment and Research Center, Dallas
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
招募中观察性研究
- Galderma Investigational Site 8238, Dallas
Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
招募中1 期
- Clinical Investigations of Texas, Dallas
其他城市的 特应性皮炎（湿疹）试验
- New York City, NY13 项研究
- Los Angeles, CA11 项研究
- Washington, DC11 项研究
- San Diego, CA10 项研究
- San Antonio, TX10 项研究
- Miami, FL9 项研究
- Birmingham, AL9 项研究
- Troy, MI8 项研究
- Huntington Beach, CA8 项研究
- Sacramento, CA8 项研究
- Tampa, FL7 项研究
- Indianapolis, IN7 项研究
Dallas的其他研究
- 乳腺癌55 项研究
- 非小细胞肺癌52 项研究
- 转移性癌症42 项研究
- 心力衰竭42 项研究
- 癌症（所有类型）37 项研究
- 前列腺癌36 项研究
- 结直肠癌33 项研究
- 肥胖症30 项研究
- 卵巢癌28 项研究
- 膀胱癌27 项研究
- 肺癌27 项研究
- 子宫内膜癌24 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。